Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

J&J chief admits mistakes at Congressional hearing

October 1, 2010 Sales and Marketing Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson chief executive William Weldon admitted yesterday that his company had failed to maintain quality standards and mishandled …
News

Doctors express serious doubts about health reforms

October 1, 2010 Sales and Marketing BMA, NHS, healthcare reform, reform

The government’s plans for radical reform of the NHS has come under attack from doctors’ association the BMA, which says …
News

Caelyx rights to revert back to Janssen

September 30, 2010 Sales and Marketing Caelyx, Janssen, Merck

Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …
News
Herceptin packs

New Herceptin data sways NICE

September 30, 2010 Sales and Marketing Herceptin, NICE, Roche

NICE is now minded to approve Roche’s Herceptin for patients with metastatic gastric cancer after receiving new efficacy data from …
News

Termeer exit could help Sanofi

September 30, 2010 Sales and Marketing Genzyme, M&A, MA, Sanofi

Genzyme’s chief executive Henri Termeer has signalled he will retire next year, a move which would help smooth the way …
News

Nestlé to pioneer ‘health science nutrition’

September 29, 2010 Sales and Marketing Alzheimer's, health science nutrition, nestle

Nestlé is to take on conditions such as diabetes, obesity, cardiovascular disease and Alzheimer’s with the creation of two research …
News
EuropeanParliamentWEB

Europe votes for patients’ access to information

September 29, 2010 Medical Communications, Sales and Marketing Europe, medicines information

Members of the European Parliament have voted in favour of giving patients across Europe access to ‘high quality information’ on …
News

Outcomes based measures for Pharma new commercial models

September 29, 2010 Sales and Marketing Kinapse, White paper

It is now widely recognised that Pharma new commercial models will rely on the principles of account management, working collaboratively …
Feature
White paper

New Commercial Realities Paper Pt 3 – The changing landscape for pharmaceutical commercial operations – roles and organisational scale

September 29, 2010 Sales and Marketing Kinapse, White paper

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the industry’s traditional commercial models based on …
Feature
White paper

European Commission eyes pharma ethics

September 27, 2010 Research and Development, Sales and Marketing European Commission, corporate responsibility, ethics

The European Commission is to examine corporate responsibility in the pharmaceutical industry with the aim of developing a series of …
News

Late stage cancer drug failure for AstraZeneca

September 27, 2010 Sales and Marketing AstraZeneca, prostate cancer, zibotentan

AstraZeneca’s oncology pipeline has suffered a further blow after prostate cancer drug zibotentan failed to meet its primary endpoint of …
News

AZ’s antiplatelet recommended for European approval

September 27, 2010 Sales and Marketing Brilinta, Brilique, Brillinta, Possia

AstraZeneca’s oral antiplatelet treatment Brilique has received a positive opinion from a key European advisory committee. A marketing authorisation for …
News

Europe committee rejects MS treatment Movectro

September 24, 2010 Sales and Marketing Cladribine, Merck Serono Movectro

The Europe Medicines Agency has rejected Merck Serono’s new multiple sclerosis treatment Movectro, saying its benefits do not outweigh its …
News

Novartis sells bladder treatment rights to Warner Chilcott

September 24, 2010 Sales and Marketing Enablex, Novartis, Warner Chilcott

Novartis is to sell the US rights to market its overactive bladder treatment Enablex to Warner Chilcott. Novartis will receive …
News

Avandia withdrawn in Europe, but remains in US

September 24, 2010 Sales and Marketing Avandia, FDA, pharmacovigilance, safety

GSK’s diabetes drug Avandia is to be withdrawn from the market in Europe because of high levels of heart attack, …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026